Baseline metabolites could predict responders with hepatitis B virus-related liver fibrosis for entecavir or combined with FuzhengHuayu tablet

Figure 3 Heatmap of all the selected potential metabolites. A: Heatmap of entecavir responders (E-R) vs entecavir no-responders (E-N) (training set); B: Heatmap of FuzhengHuayu tablet (FZHY) + entecavir responders (F-R) vs FZHY + entecavir no-responders (F-N) (training set); C: Heatmap of patients vs volunteers (training set); D: Heatmap of E-R vs E-N (validation set); E: Heatmap of F-R vs F-N (validation set); F: Heatmap of patients vs volunteers (validation set). CA: Citric acid; GCDCA: Glycochenodeoxycholic acid; TCA: Tricarboxylic acid; TCDCA: Aurochenodeoxycholic acid; DHA: Docosahexaenoic acid; DPA: Docosapentaenoic acid; EPA: Eicosapentaenoic acid.